Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,765.60
(
-1.52%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.88
(
7.18%
)
Bitcoin
71,323.92
(
-3.54%
)
News Focus
News Focus
Post# of 257255
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 164178

Wednesday, 07/17/2013 12:35:55 PM

Wednesday, July 17, 2013 12:35:55 PM

Post# of 257255

The revision was presumably the FDA’s permission to conduct the DDI study, and I’m guessing that the second drug in the DDI study is ENTA’s EDP-239.





Wouldn't a Phase-2 DDI study of DEB025 and EDP-239 (two clinical-stage compounds) be listed on the clinicaltrials website?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now